The Brief
What Tempus Precision Medicine does and why it matters
Tempus analyzes genomic and clinical data using AI to identify optimal cancer treatments for individual patients. The platform gives oncologists real-world evidence from the largest genomic database in oncology.
Builder’s Brief
Tempus Precision Medicine is a healthcare tool on Falcoscan. AI precision medicine platform for cancer genomics. Falcoscan rates Tempus Precision Medicine with an Opportunity score of 88/100, a Saturation score of 10/100, and a Wrapper-risk score of 10/100. Market signal: hot. Tempus Precision Medicine is founded in 2015, currently at Series_a stage. Pricing: Paid. Rating 4.7/5 across 1 tracked views.